Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Lineage Cell Therapeutics, Inc. Increase (Decrease) in Accounts Receivable

Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Accounts Receivable of -$173.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06

  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$19.00K, a 144.19% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$154.00K.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $827.00K, a 254.94% increase year-over-year.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$130.00K, a 176.92% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $316.00K.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$106.00K, a 123.77% decline from fiscal 2023.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $446.00K.
  • Lineage Cell Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$50.31M, a 5970.95% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30-$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$173.00K
10-Q · filed 2026-08-06
$654.00K
derived: sum of 3 quarters · filed 2026-08-06
$524.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$154.00K
10-Q · filed 2026-05-12
$673.00K
derived: sum of 2 quarters · filed 2026-05-12
$543.00K
derived: sum of 3 quarters · filed 2026-05-12
$586.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$827.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$697.00K
derived: sum of 2 quarters · filed 2026-03-05
$740.00K
derived: sum of 3 quarters · filed 2026-08-06
$316.00K
10-K · filed 2026-03-05
2025-09-30-$130.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$87.00K
derived: sum of 2 quarters · filed 2026-08-06
-$511.00K
10-Q · filed 2025-11-06
-$278.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$43.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$381.00K
10-Q · filed 2026-08-06
-$148.00K
derived: sum of 3 quarters · filed 2026-08-06
$21.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$424.00K
10-Q · filed 2026-05-12
-$191.00K
derived: sum of 2 quarters · filed 2026-05-12
-$22.00K
derived: sum of 3 quarters · filed 2026-05-12
$138.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$233.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$402.00K
derived: sum of 2 quarters · filed 2026-03-05
$562.00K
derived: sum of 3 quarters · filed 2026-03-05
-$106.00K
10-K · filed 2026-03-05
2024-09-30$169.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$329.00K
derived: sum of 2 quarters · filed 2025-11-06
-$339.00K
10-Q · filed 2025-11-06
-$34.00K
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$160.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$508.00K
10-Q · filed 2025-08-12
-$203.00K
derived: sum of 3 quarters · filed 2025-08-12
-$209.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$668.00K
10-Q · filed 2025-05-13
-$363.00K
derived: sum of 2 quarters · filed 2025-05-13
-$369.00K
derived: sum of 3 quarters · filed 2025-05-13
-$127.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$305.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$299.00K
derived: sum of 2 quarters · filed 2025-03-10
$541.00K
derived: sum of 3 quarters · filed 2025-03-10
$446.00K
10-K · filed 2025-03-10
2023-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$236.00K
derived: sum of 2 quarters · filed 2024-11-14
$141.00K
10-Q · filed 2024-11-14
$33.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$242.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$147.00K
10-Q · filed 2024-08-08
$39.00K
derived: sum of 3 quarters · filed 2024-08-08
-$56.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$95.00K
10-Q · filed 2024-05-09
-$203.00K
derived: sum of 2 quarters · filed 2024-05-09
-$298.00K
derived: sum of 3 quarters · filed 2024-05-09
-$88.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$108.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$203.00K
derived: sum of 2 quarters · filed 2024-03-07
$7.00K
derived: sum of 3 quarters · filed 2024-03-07
-$50.31M
10-K · filed 2024-03-07
2022-09-30-$95.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$115.00K
derived: sum of 2 quarters · filed 2023-11-09
-$50.21M
10-Q · filed 2023-11-09
-$49.45M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$210.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$50.11M
10-Q · filed 2023-08-10
-$49.36M
derived: sum of 3 quarters · filed 2023-08-10
-$49.61M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$50.32M
10-Q · filed 2023-05-11
-$49.57M
derived: sum of 2 quarters · filed 2023-05-11
-$49.82M
derived: sum of 3 quarters · filed 2023-05-11
-$49.60M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$753.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$504.00K
derived: sum of 2 quarters · filed 2023-03-09
$722.00K
derived: sum of 3 quarters · filed 2023-03-09
$857.00K
10-K · filed 2023-03-09
2021-09-30-$249.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$31.00K
derived: sum of 2 quarters · filed 2022-11-10
$104.00K
10-Q · filed 2022-11-10
-$132.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$218.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$353.00K
10-Q · filed 2022-08-11
$117.00K
derived: sum of 3 quarters · filed 2022-08-11
$191.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$135.00K
10-Q · filed 2022-05-12
-$101.00K
derived: sum of 2 quarters · filed 2022-05-12
-$27.00K
derived: sum of 3 quarters · filed 2022-05-12
-$86.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$236.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$162.00K
derived: sum of 2 quarters · filed 2022-03-10
-$221.00K
derived: sum of 3 quarters · filed 2022-03-10
-$287.00K
10-K · filed 2022-03-10
2020-09-30$74.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$15.00K
derived: sum of 2 quarters · filed 2021-11-10
-$51.00K
10-Q · filed 2021-11-10
-$44.00K
10-Q · filed 2020-11-04
$116.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$59.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$125.00K
10-Q · filed 2021-08-12
$42.00K
derived: sum of 3 quarters · filed 2021-08-12
-$1.46M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$66.00K
10-Q · filed 2021-05-13
$101.00K
derived: sum of 2 quarters · filed 2021-05-13
-$1.40M
derived: sum of 3 quarters · filed 2021-05-13
-$1.15M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$167.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$1.33M
derived: sum of 2 quarters · filed 2021-03-11
-$1.08M
derived: sum of 3 quarters · filed 2021-03-11
-$467.00K
10-K · filed 2021-03-11
2019-09-30-$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
-$1.25M
derived: sum of 2 quarters · filed 2020-11-04
-$634.00K
10-Q · filed 2020-11-04
-$573.00K
derived: sum of 4 quarters · filed 2020-11-04
2019-06-30$249.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$863.00K
10-Q · filed 2020-08-06
$924.00K
derived: sum of 3 quarters · filed 2020-08-06
-$51.00K
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$614.00K
10-Q · filed 2020-05-07
$675.00K
derived: sum of 2 quarters · filed 2020-05-07
-$300.00K
derived: sum of 3 quarters · filed 2020-05-07
$531.00K
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$914.00K
derived: sum of 2 quarters · filed 2020-03-12
-$83.00K
derived: sum of 3 quarters · filed 2020-03-12
-$46.00K
10-K · filed 2020-03-12
2018-09-30-$975.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$144.00K
derived: sum of 2 quarters · filed 2019-11-12
-$107.00K
10-Q · filed 2019-11-12
-$840.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$831.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$868.00K
10-Q · filed 2019-08-08
$135.00K
derived: sum of 3 quarters · filed 2019-08-08
$1.34M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$37.00K
10-Q · filed 2019-05-09
-$696.00K
derived: sum of 2 quarters · filed 2019-05-09
$508.00K
derived: sum of 3 quarters · filed 2019-05-09
$457.00K
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$733.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$471.00K
derived: sum of 2 quarters · filed 2019-03-14
$420.00K
derived: sum of 3 quarters · filed 2019-03-14
$172.00K
10-K · filed 2019-03-14
2017-09-30$1.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$1.15M
derived: sum of 2 quarters · filed 2018-11-08
$905.00K
10-Q · filed 2018-11-08
-$237.00K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$299.00K
10-Q · filed 2018-08-02
-$1.44M
derived: sum of 3 quarters · filed 2018-08-02
-$540.00K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$248.00K
10-Q · filed 2018-05-10
-$1.39M
derived: sum of 2 quarters · filed 2018-05-10
-$489.00K
derived: sum of 3 quarters · filed 2018-05-10
-$471.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$241.00K
derived: sum of 2 quarters · filed 2018-03-15
-$223.00K
derived: sum of 3 quarters · filed 2018-03-15
-$187.00K
10-K · filed 2018-03-15
$39.00K
10-K · filed 2017-03-16
2016-09-30$901.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$919.00K
derived: sum of 2 quarters · filed 2017-11-09
$955.00K
10-Q · filed 2017-11-09
$1.13M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$54.00K
10-Q · filed 2017-08-09
$232.00K
derived: sum of 3 quarters · filed 2018-03-15
$203.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$36.00K
10-Q · filed 2017-05-10
$214.00K
derived: sum of 2 quarters · filed 2018-03-15
$185.00K
derived: sum of 3 quarters · filed 2018-03-15
$287.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$178.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$149.00K
derived: sum of 2 quarters · filed 2018-03-15
$251.00K
derived: sum of 3 quarters · filed 2018-03-15
$80.00K
10-K · filed 2018-03-15
$248.00K
10-K · filed 2016-03-15
2015-09-30-$29.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$73.00K
derived: sum of 2 quarters · filed 2016-11-04
-$98.00K
10-Q · filed 2016-11-04
$114.00K
10-Q · filed 2015-11-09
-$110.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$102.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$69.00K
10-Q · filed 2016-08-09
-$4.00K
10-Q · filed 2015-08-10
-$81.00K
derived: sum of 3 quarters · filed 2017-03-16
-$32.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$171.00K
10-Q · filed 2016-05-10
$56.60K
10-Q · filed 2015-05-08
-$183.00K
derived: sum of 2 quarters · filed 2017-03-16
-$134.00K
derived: sum of 3 quarters · filed 2017-03-16
-$121.44K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$37.00K
derived: sum of 2 quarters · filed 2017-03-16
$49.56K
derived: sum of 3 quarters · filed 2017-03-16
$74.00K
10-K · filed 2017-03-16
$73.78K
10-K · filed 2015-03-11
2014-09-30$49.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$61.56K
derived: sum of 2 quarters · filed 2015-11-09
$86.00K
10-Q · filed 2015-11-09
$86.12K
10-Q · filed 2014-11-07
$200.69K
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$12.56K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$37.00K
10-Q · filed 2015-08-10
$37.00K
10-Q · filed 2014-08-11
$151.69K
derived: sum of 3 quarters · filed 2016-03-15
$192.30K
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$24.44K
10-Q · filed 2015-05-08
$139.13K
derived: sum of 2 quarters · filed 2016-03-15
$179.74K
derived: sum of 3 quarters · filed 2016-03-15
$122.53K
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$114.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$155.30K
derived: sum of 2 quarters · filed 2016-03-15
$98.08K
derived: sum of 3 quarters · filed 2016-03-15
$181.00K
10-K · filed 2016-03-15
$180.93K
10-K · filed 2014-03-17
2013-09-30$40.61K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$16.61K
derived: sum of 2 quarters · filed 2014-11-07
$66.31K
10-Q · filed 2014-11-07
-$429.57K
derived: sum of 4 quarters · filed 2015-03-11
2013-06-30-$57.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$25.70K
10-Q · filed 2014-08-11
-$470.18K
derived: sum of 3 quarters · filed 2015-03-11
-$22.78K
derived: sum of 4 quarters · filed 2015-03-11
2013-03-31$82.92K
10-Q · filed 2014-05-12
-$412.96K
derived: sum of 2 quarters · filed 2015-03-11
$34.44K
derived: sum of 3 quarters · filed 2015-03-11
$50.08K
derived: sum of 4 quarters · filed 2015-03-11
2012-12-31-$495.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11
-$48.48K
derived: sum of 2 quarters · filed 2015-03-11
-$32.84K
derived: sum of 3 quarters · filed 2015-03-11
-$36.32K
10-K · filed 2015-03-11
2012-09-30$447.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$463.04K
derived: sum of 2 quarters · filed 2013-11-12
$459.56K
10-Q · filed 2013-11-12
$554.96K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30$15.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$12.16K
10-Q · filed 2013-08-09
$143.04K
10-Q · filed 2012-08-09
$107.56K
derived: sum of 3 quarters · filed 2014-03-17
$10.91K
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31-$3.48K
10-Q · filed 2013-05-10
$91.92K
derived: sum of 2 quarters · filed 2014-03-17
-$4.73K
derived: sum of 3 quarters · filed 2014-03-17
-$1.59K
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31$95.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$1.24K
derived: sum of 2 quarters · filed 2014-03-17
$1.90K
derived: sum of 3 quarters · filed 2014-03-17
$120.68K
10-K · filed 2014-03-17
2011-09-30-$96.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$93.51K
derived: sum of 2 quarters · filed 2012-11-09
$25.27K
10-Q · filed 2012-11-09
-$25.27K
10-Q · filed 2011-11-08
$126.67K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$3.14K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$121.92K
10-Q · filed 2012-08-09
-$121.92K
10-Q · filed 2011-08-09
$223.32K
derived: sum of 3 quarters · filed 2013-03-18
$167.22K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$118.78K
10-Q · filed 2012-05-10
$220.18K
derived: sum of 2 quarters · filed 2013-03-18
$164.08K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$101.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$45.30K
derived: sum of 2 quarters · filed 2013-03-18
$77.91K
10-K · filed 2013-03-18
2010-09-30-$56.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$23.49K
10-Q · filed 2011-11-08
2010-06-30$32.61K
10-Q · filed 2011-08-09
2009-12-31$349.00
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51